Neurological outcome in school-age children after in utero exposure to coumarins

J Wesseling1, D Van Driel, M Smrkovsky

  • 1Department of Paediatrics, Beatrix Children's Hospital, University Hospital Groningen, P.O. Box 30.001, 9700 RB Groningen, Netherlands.

Insights

Prenatal exposure to coumarin medications increases the risk of minor neurological dysfunction (MND) in school-aged children. This risk is higher with second or third-trimester exposure and shows a dose-response relationship.

Area of Science:

  • Neuroscience
  • Developmental Pediatrics
  • Pharmacology

Background:

  • Prenatal exposure to certain medications can impact child development.
  • Coumarins are anticoagulant medications used during pregnancy.
  • The long-term neurological effects of prenatal coumarin exposure require further investigation.

Purpose of the Study:

  • To assess the neurological outcomes in children exposed prenatally to coumarin derivatives.
  • To determine the association between gestational coumarin exposure and minor neurological dysfunction (MND).

Main Methods:

  • A cohort study comparing 306 children exposed to coumarins in utero with 267 matched unexposed children.
  • Neurological examinations focused on identifying minor neurological dysfunction (MND).
  • Statistical analysis included calculating odds ratios (OR) and confidence intervals (CI).

Main Results:

  • No children exhibited severe neurological abnormalities.
  • Prenatal coumarin exposure was associated with an increased risk of MND (OR 1.9).
  • Exposure during the second or third trimester showed a higher risk (OR 2.1), with a dose-response relationship observed.

Conclusions:

  • Gestational coumarin exposure is linked to an increased risk of mild neurological dysfunction in school-aged children.
  • The findings suggest coumarins may influence brain development, leading to subtle neurological deficits.
  • Further research is warranted to understand the mechanisms and long-term implications.

Related Concept Videos